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Abstract
In patients who experience unilateral chronic pain, abnormal sensory perception at the non-painful side has been reported.
Contralateral sensory changes in these patients have been given little attention, possibly because they are regarded as
clinically irrelevant. Still, bilateral sensory changes in these patients could become clinically relevant if they challenge the
correct identification of their sensory dysfunction in terms of hyperalgesia and allodynia. Therefore, we have used the
standardized quantitative sensory testing (QST) protocol of the German Research Network on Neuropathic Pain (DFNS) to
investigate somatosensory function at the painful side and the corresponding non-painful side in unilateral neuropathic
pain patients using gender- and age-matched healthy volunteers as a reference cohort. Sensory abnormalities were
observed across all QST parameters at the painful side, but also, to a lesser extent, at the contralateral, non-painful side.
Similar relative distributions regarding sensory loss/gain for non-nociceptive and nociceptive stimuli were found for both
sides. Once a sensory abnormality for a QST parameter at the affected side was observed, the prevalence of an abnormality
for the same parameter at the non-affected side was as high as 57% (for Pressure Pain Threshold). Our results show that
bilateral sensory dysfunction in patients with unilateral neuropathic pain is more rule than exception. Therefore, this
phenomenon should be taken into account for appropriate diagnostic evaluation in clinical practice. This is particularly true
for mechanical stimuli where the 95% Confidence Interval for the prevalence of sensory abnormalities at the non-painful
side ranges between 33% and 50%.
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Introduction
In clinical practice, the assessment of chronic pain includes
documentation of pain location, intensity, quality and onset/
duration aimed to elucidate the underlying pathophysiological
mechanism. Sensory testing is an important part of this assessment
which is aimed at identifying phenomena such as hyperalgesia
(increased response to painful stimuli) and allodynia (painful
response to normally non-painful stimuli) for thermal and
mechanical stimuli [1]. For this clinical evaluation, patients are
generally used as their own control when comparing profiles of
sensory dysfunction at the painful side with the contralateral non-
painful area [1,2]. The correct identification of the specifics of
sensory dysfunction in each chronic pain patient is obviously of
major importance for addressing the underlying mechanism such
as peripheral or spinal hyperexcitability and has consequences for
pharmacological treatment.
There are only a few studies reporting bilateral sensory
abnormalities in chronic pain conditions. Huge and co-workers,
2008 investigated thermal sensory function at the affected and
non-affected side of acute and chronic complex regional pain
syndrome (CRPS) patients and found bilateral sensory changes for
both patient groups [3]. Another study investigating bilateral
warmth/cold detection and heat/cold pain thresholds over the
hand/wrist in patients with unilateral carpal tunnel syndrome
(CTS) revealed bilateral thermal hyperalgesia in patients with
strictly unilateral CTS compared to controls [4]. In a similar
patient population, Ferna ´ndez-de-las-Pen ˜as and colleagues (2009)
reported bilateral pressure pain hyperalgesia in patients with
unilateral CTS [5].
In spite of the studies referred to above, the occurrence of
contralateral sensory changes in situations where the pain is
experienced only unilaterally is still not generally acknowledged.
Possibly this is because it is regarded clinically irrelevant.
However, bilateral sensory changes could become clinically
relevant in patients with unilateral pain if they challenge the
correct qualification of sensory dysfunction. For example, if a
mechanical stimulus which is known to be slightly painful
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patient as equally painful at both sides, one could conclude normal
sensory functioning. However, if both the non-affected and
affected side of this patient are hyperalgesic for this particular
stimulus, the conclusion of a mechanical hyperalgesia could be
overseen.
As the neuropathic pain is characterized by both, positive and
negative sensory phenomena, it is critical for those phenomena to
be captured and, for their optimal utility, to be measured
quantitatively. The German Research Network on Neuropathic
Pain (DNFS) established a standardized Quantitative Sensory
Testing (QST) protocol which allows a comprehensive somato-
sensory characterisation of chronic neuropathic pain patients,
using reference values from healthy volunteers [6,7]. This protocol
uses 13 different mechanical and thermal stimuli (e.g. graded von
Frey filaments, pin-prick devices, a pressure algometer, and
quantitative thermo-testing). It takes about 30 minutes to test
one location of the body in healthy volunteers and about 45
minutes in patients. This QST battery tests different sub-
modalities of nerve fibres involved in the transduction of sensory
information from the periphery to the spinal cord such as Ab-fibre,
Ad-fibre and C-fibre [6,7].
There is a long tradition of quantitative measurement of somatic
sensory function, well documented in a number of publications
[8,9,10,11] and it has been shown to be adequate with respect to
reliability and validity [12]. Several publications show that also
QST is valid, reliable and sensitive to quantify sensory abnormal-
ities [13,14,15,16].
By using reference values from healthy volunteers, QST does
not rely on reference values obtained from the patient’s own
contralateral side. Thus, it offers a unique opportunity to study
bilateral somatosensory function in patients with chronic unilateral
pain in a detailed, standardized manner.
Based on previous reports we hypothesize that bilateral
somatosensory abnormalities are frequently present in unilateral
chronic pain patients and that bilateral sensory changes may exist
for the same QST parameter. To test this we selected a large
cohort of patients with unilateral neuropathic pain. We examined
the painful side and its corresponding contralateral area using the
standardized DNFS QST protocol comparing values with those
obtained from age- and gender-matched healthy volunteers.
Methods
Ethics Statement
The study adhered to the declaration of Helsinki and was
approved by the independent, medical ethical committee ‘‘Sticht-
ing Beoordeling Ethiek Bio-Medisch Onderzoek’’, P.O. Box 1004,
9400 BA Assen, The Netherlands. This committee is acknowl-
edged by the Central Committee on Research Involving Human
Subjects (known by its Dutch initials, CCMO). Patients and
healthy controls were recruited from the local region. All
participants signed an informed consent form.
Description of Healthy Controls
In total, 209 age- and gender-matched healthy volunteers (age
range 20–73 years), 138 females (age 45.3613.4 years) and 71
males (age 48.7614.0 years) underwent the QST assessments on
their dorsal hand and foot. These body locations have been
indicated by Rolke et al., 2006 as reference sites for QST [6]. A
previous study concluded that there were no significant differences
in QST parameters between the right and left sides of the body in
healthy volunteers [6], thus we obtained QST reference values
from one side of the body. In total, 418 QST references from the
upper and the lower extremity were obtained. Healthy volunteers
were identified according to medical history. Subjects were
specifically questioned about previous injuries or diseases. The
healthy subjects did not use pain medication regularly and were
free of medication at the time of the assessments.
Description of the Patient Cohort
Patients were recruited from the outpatient Department of the
Pain Management Unit of the University Medical Center
Groningen, The Netherlands. All patients were diagnosed as
suffering from neuropathic pain by the physicians of the pain
management unit. Neuropathic pain diagnosis was made on
grounds of coherent patient history, medical history, physical
examination, including neurologic function tests such as EMG.
Each clinical diagnosis was additionally confirmed by an
experienced pain specialist of the Pain Management Unit based
on patient’s files. In total, 81 neuropathic pain patients (43 females
age 52.6612.7 years and 38 males age 49.8613.0 years)
underwent the QST assessment, each at the area where the most
profound pain was experienced and at their contralateral
counterpart (leg: n=42, arm: n=19, thorax: n=7, groin: n=4,
shoulder: n=3, back: n=2, neck: n=1, abdomen: n=1, flank:
n=1).
Prior to undergoing the QST assessments, patients were asked
to rate their ongoing pain level using a Numerical Rating Scale
(NRS) of ‘0’ indicating ‘‘no pain’’, and ‘100’ indicating ‘‘most
intense pain imaginable’’. Patients did not discontinue their
regular pain treatment if applicable.
Quantitative Sensory Testing (QST)
The QST battery consisted of seven tests, measuring thirteen
parameters and was applied according to the standardized
protocol of Rolke et al., 2006 [6]. QST was performed by two
research nurses, who underwent a comprehensive training at the
DNFS in Germany. All tests were performed at the same research
facility of PRA Int., Groningen, The Netherlands. The average
room temperature was 22.8uC; SD 61.8uC.
Thermal QST tests were performed using the Medoc Pathway
System (Medoc, Israel) and consisted of six parameters: threshold
assessments for warm and cold detection (WDT, CDT) and heat
pain and cold pain (HPT, CPT). In addition, paradoxical heat
sensations (PHS) during the thermal sensory limen (TSL)
procedure of alternating warm and cold stimuli were identified.
Mechanical QST tests consisted of seven different parameters.
The mechanical detection threshold (MDT) was determined with
a standardized set of modified von Frey filaments (Optihair2-Set,
Marstock Nervtest, Germany). The mechanical pain threshold
(MPT) was measured using a set of seven pinprick devices (flat
contact area of 0.2 mm in diameter) with fixed stimulus intensities
that exerted forces of 8, 16, 32, 64, 128, 256, and 512 mN.
Mechanical pain sensitivity (MPS) was assessed using the same set
of seven weighted pinprick stimuli to obtain a stimulus–response
function for pinprick-evoked pain. Dynamic mechanical allodynia
(DMA) was assessed as part of the test above, using a set of three
light tactile stimulators as dynamic innocuous stimuli: cotton wisp,
cotton wool tip fixed to an elastic strip and a standardized brush
(SENSElab No.5, Somedic, Sweden).
Vibration detection threshold (VDT) was performed with a
Rydel–Seiffer graded tuning fork (64 Hz, 8/8 scale) that was
placed over a bony prominence. The wind up ratio (WUR) test
was assessed with a pinprick intensity of 256 mN. The pressure
pain threshold (PPT) was determined over muscle with a pressure
gauge device (FDN200, Wagner Instruments, CT, USA).
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The Medoc Pathway System was maintained and calibrated
according to the manufactures guideline (calibration took place
every three months, cleaning of the system every 6 months). All
mechanical devices were inspected regarding their function prior
to each testing. The standardized von Frey filaments (Marstock)
were replaced once a filament of concern was bent. Each pinprick
device underwent a functionality test and inspection of the contact
tip. The tip was replaced once bent including a calibration of the
device. Two of the three light tactile stimulators i.e. cotton wisp
and cotton wool tip fixed to an elastic strip were replaced after
each testing. The standardized brush was replaced once the brush
hairs were not conforming to the usual shape (typically every
6 months). The pressure gauge device and tuning fork were not
replaced during the assessment period.
Z-transformation of QST Data
QST data of patients with neuropathic pain were compared
with reference data from gender and age matched healthy
volunteers. Both, patients and healthy subjects were divided into
three age groups each (20–45 years of age, 46–60 years of age and
61–75 years of age). QST values of chronic pain locations and
their mirror image area at the upper extremities were compared to
QST reference values obtained from the dorsal hand of healthy
controls (n=63 for females and n=29 for males for age group 20–
45 years; n=58 for females and n=24 for males for age
group 46–60 years; n=17 for females and n=18 for males for
age group 61–75), whereas values from chronic pain locations at
lower extremities and their mirror image area were compared to
reference values obtained from the dorsal foot of healthy controls
(n=63 for females and n=29 for males for age group 20–45 years;
n=58 for females and n=24 for males for age group 46–60 years;
n=17 for females and n=18 for males for age group 61–75). QST
values from each patient were transformed to z-scores as described
by Rolke et al., 2006 [6]. A score above 1.96 or below 21.96 falls
outside the 95% confidence interval of the mean reference value
and was considered as a sensory abnormality. Abnormalities were
subsequently categorized as either a sensory gain or a sensory loss.
Because ‘‘dynamic mechanical allodynia’’ (DMA) never occurs
in healthy volunteers, the QST parameter could not be used for z-
score analysis. Alternatively, patients ratings greater than NRS 10
(scale 0–100) were regarded as clinically relevant and were
identified as abnormal.
For the QST parameter ‘‘wind up ratio’’ (WUR), twenty-three
patients (thirteen assessments at the affected side and ten
assessments at the contralateral side) rated the single pinprick
stimulus as ‘‘0’’ making ratio calculations (painfulness of one
pinprick stimulation vs. painfulness of a train of ten pinprick
stimulations) for Wind-up impossible. For these patients WUR was
not used for subsequent analyses.
Proportion of Patients with Sensory Abnormalities at the
Affected Side
For each QST parameter, the proportion of patients with
sensory abnormalities at the painful, affected side was calculated.
To estimate the prevalence of sensory abnormalities in the general
patient population we calculated the 95% confidence intervals of
the calculated proportions using the ‘Wilson Estimate’ of
proportion [17]. These 95% confidence intervals give an
indication of the expected range of the occurrence of abnormal-
ities in the general pain patient population with neuropathic pain
and tests whether the proportion differs significantly from zero
(p,0.05).
Proportion of Patients with Sensory Abnormalities at the
Contralateral Side
For each QST parameter, the proportion of patients with
sensory abnormalities at the non-painful, contralateral side was
calculated applying the same procedure (see 2.4.2.).
Proportion of Patients with Sensory Abnormalities for the
Same QST Parameter at the Affected and Contralateral
Side
For each patient, the presence or absence of a sensory
abnormality at the contralateral side for a particular QST
parameter was determined when the patient had already shown
a sensory abnormality for this QST parameter at the affected side.
This allowed the direct identification of a relationship between
bilateral sensory abnormalities for the same QST parameter. To
increase statistical power we recalculated the above proportions
but now pooled the thermal QST parameters (CPT, HPT, WDT,
CDT, TSL and PHS) into one overall thermal QST domain and
pooled the mechanical QST parameters (WUR, MPT, MPS,
MDT, VDT, PPT and ALL) into one overall mechanical domain.
Again we estimated the prevalence of sensory abnormalities in
the general patient population with the ‘Wilson Estimate’. All
proportions are reported as percentages.
Correlation between Background Pain and Sensory
Abnormalities
To identify correlations between ongoing background pain and
values for each QST parameter Pearson correlations were
calculated.
Correlation between Numbers of Sensory Abnormalities
at the Affected and Contralateral Side
The overall numbers of sensory abnormalities for the affected
and contralateral side across the thirteen QST parameters were
compared to identify possible relationships using Pearson corre-
lations.
Results
QST Observations in Healthy Controls
From the healthy volunteer cohort (n=209) investigated in this
study, a total of 418 locations were assessed and 5434 measure-
ments were analysed by means of z-score profiling.
Sensory Function in Healthy Controls
Although the majority of the QST results obtained in healthy
volunteers confirmed normal sensory function for this cohort,
incidental sensory abnormalities (4.3%) were observed for all QST
parameters with the exception of DMA. Age, -gender, -and
location matched normative QST data are presented in Table S1.
Out of the total of 418 different body areas that were tested
across all healthy controls 64.0% (258 locations) showed normal
sensory function and 36.0% (160 locations) showed a sensory
abnormality for at least one QST parameter. Sensory abnormal-
ities were regarded as sensory gain in 20.3%, sensory loss in 12.0%
and a mixture of sensory gain and sensory loss in 3.6% of the cases
(Fig. 1).
Demographics of Patients
Demographic data of the patients are shown in Table 1. All
patients reported ongoing spontaneous pain only at their affected
side ranging from 3 to 90 (Mean 64.1621.4 SD) on a 0–100 NRS
just before the QST assessment took place. The aetiology of
Bilateral Sensory Changes in Neuropathic Pain
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central pain patients. The largest subgroups developed pain after a
surgical intervention (n=27) including one patient with Complex
Regional Pain Syndrome-II (CRPS) followed by an accident with
trauma including fractures (n=26). Other patients reported pain
after failed back surgery (n=8), Herniated nucleus pulposus
(n=7), amputation (n=4), Radiotherapy (n=3), peripheral nerve
entrapment (n=2). Three patients were diagnosed with posther-
petic neuralgia and one patient was with Meralgia paresthetica
(see Table 1).
QST Observations in Patients
For the 81 patients investigated in this study, 2106 QST data
measurements were obtained from both the affected and
contralateral side. The total of 2083 measurements were analysed
by means of z-score profiling.
Sensory Function in Patients
In patients with neuropathic pain, sensory abnormalities were
observed in all QST parameters at both affected and contralateral
side (Fig. 2). In our patient cohort, 91% had at least one QST
abnormality at the affected side. Of the patients without sensory
abnormalities at the affected side (9%), 28% still showed at least
one sensory abnormality at the contralateral side. At the affected
side, 49% of the patients had a mixture of sensory gain and loss,
28% had only sensory gain (hyperalgesia), and 14% had only
sensory loss (hypoesthesia) (Fig. 1).
At the contralateral side, 74% of the patients had at least one
QST abnormality. In 24% of the patients a mixture of sensory
gain and loss was present. Almost 35% of the patients showed only
sensory gain and 16% had only sensory loss at the contralateral
side (Fig. 1).
95% Confidence Intervals confirmed that the prevalence of
normal sensory function differs significantly between healthy
controls and patients at the painful and non-painful side (all
p,0.05). A significant difference was also present between the
painful side and non-painful side of the patients (p,0.05).
Sensory Changes at Patients Affected Side
Sensory abnormalities at the affected side ranged from 8.6%
(n=7) for CPT to 49.4% (n=40) for PPT. 95% Confidence
Intervals confirmed that the prevalence differed significantly from
zero (p,0.05) for all QST parameters with highest incidence for
MPT (95CI: 27%-48%) and PPT (95CI: 39%-60%) (Table 2A).
For the nociceptive parameters (CPT, HPT, PPT, MPS, WUR)
there were predominantly changes reflecting hyperalgesia, where-
as for the non-nociceptive ones (CDT, WDT, TSL, MDT, VDT)
they reflected hypoesthesia (Fig. 3).
For the nociceptive parameters CPT and HPT, thermal pain
threshold were decreased indicating a thermal hyperalgesia. An
increased pain due to blunt pressure (PPT) and an increased
sensitivity to mechanical pain (MPS) were observed indicating only
hyperalgesia for these parameters. For MPT a greater incidence
for mechanical hypo- than hypersensitivity was detected. WUR
was more frequently increased than decreased indicating a greater
incidence for hyper- than hyposensitivity.
Thermal hypoesthesias were observed also in most of the
patients for CDT, WDT and TSL. For MDT there was
predominantly a sensory loss observed indicating a mechanical
hypoesthesia. It was possible to detect hyperesthesia for VDT for
one patient, but for the large majority VDT responses indicated
hypoesthesia.
In 27% (n=22) of the patients a sensory gain for PHS was
detected at the affected side. DMA was present in 26% of the
patients, in 6% of very mild intensity, however, 20% of patients
Figure 1. Sensory findings in healthy controls and neuropathic pain patients Sensory findings (gain and/or loss of sensory function) in %
for healthy controls (n=208 with 418 test sides) and for patients at the affected and contralateral side (n=81). Sensory abnormalities were defined as
Z score ,21.96 or .1.96 corresponding with 95% of values obtained from healthy volunteers. ‘‘No sensory abnormalities’’: none of the Quantitative
Sensory Testing (QST) parameters were outside the 95% CI. ‘‘Only sensory gain’’: at least one QST parameter indicating thermal or mechanical
hyperesthesia or hyperalgesia without the presence of hypoesthesia or hypoalgesia. ‘‘Only sensory loss’’: at least one QST parameter indicating
thermal or mechanical hypoesthesia or hypoalgesia without the presence of hyperesthesia or hyperalgesia. ‘‘Sensory gain and loss’’: at least one
positive sign combined with one negative sign.
doi:10.1371/journal.pone.0037524.g001
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ID Gender Age NRS Cause of Pain Nerve Clinical diagnosis A.-side C.- side
1 F 25 70 Accident with trauma N. digitalis peripheral nerve injury 3 2
2 F 39 80 Postsurgical pain N. radialis peripheral nerve injury 1 1
3 F 41 40 Postsurgical pain TH 11 peripheral nerve injury 3 0
4 F 41 70 Metacarpal fracture N. ulnaris peripheral nerve injury 3 0
5 F 46 75 Accident with trauma C 6 peripheral nerve injury 1 1
6 F 46 85 Postsurgical pain N. digitalis palmaris peripheral nerve injury 2 2
7 F 46 40 Amputation N. cutaneous brachii peripheral nerve injury 3 1
8 F 48 60 Accident with trauma N. ulnaris peripheral nerve injury 0 0
9 F 51 80 Peripheral nerve entrapment C 6/7 peripheral nerve injury 4 2
10 F 51 70 Postsurgical pain TH 11/12 peripheral nerve injury 2 2
11 F 53 80 Radiotherapy TH 3–TH 6 peripheral nerve injury 4 3
12 F 64 60 Accident with trauma TH 9/10 peripheral nerve injury 3 1
13 F 66 75 Accident with trauma Cranial nerve XI peripheral nerve injury 3 2
14 F 67 85 Herniated nucleus pulposus TH 6/7 peripheral nerve injury 3 0
15 F 71 3 Herpes zoster TH 12 postherpetic neuralgia 6 1
16 F 73 25 Herpes zoster TH 11 postherpetic neuralgia 3 0
17 F 27 70 Femur fracture N. sapheneus internus peripheral nerve injury 8 2
18 F 36 80 Cruris fracture N. tibialis peripheral nerve injury 6 3
19 F 37 80 Postsurgical pain TH 9/10 peripheral nerve injury 2 3
20 F 40 70 Amputation N. tibialis peripheral nerve injury 4 1
21 F 41 70 Postsurgical pain N. peroneus/N. tibialis peripheral nerve injury 4 0
22 F 42 70 Herniated nucleus pulposus N. peroneus prof. peripheral nerve injury 4 1
23 F 43 75 Accident with trauma N. tibialis peripheral nerve injury 4 2
24 F 43 75 Meralgia paresthetica N. femoralis peripheral nerve injury 2 3
25 F 46 75 Accident with trauma N. peroneal peripheral nerve injury 3 2
26 F 47 80 Accident with trauma L 4 peripheral nerve injury 2 3
27 F 49 50 Accident with trauma N. tibialis peripheral nerve injury 4 5
28 F 49 30 Failed back surgery L 5-S 1 peripheral nerve injury 5 3
29 F 50 10 Radiotherapy Plexus brachialis peripheral nerve injury 3 3
30 F 52 100 Failed back surgery L 5/6 peripheral nerve injury 3 2
31 F 55 90 Herniated nucleus pulposus L 5-S 1 peripheral nerve injury 3 2
32 F 56 90 Postsurgical pain N. Suralis peripheral nerve injury 2 1
33 F 58 90 Postsurgical pain N. femoralis peripheral nerve injury 2 1
34 F 59 60 Postsurgical pain N. plantaris peripheral nerve injury 5 1
35 F 61 80 Postsurgical pain L 4/5 peripheral nerve injury 2 3
36 F 62 80 Failed back surgery L 5-S 1 peripheral nerve injury 6 0
37 F 65 70 Herniated nucleus pulposus L 5-S 1 peripheral nerve injury 5 6
38 F 65 50 Amputation Peroneal nerves peripheral nerve injury 7 1
39 F 66 70 Postsurgical pain N. peroneus peripheral nerve injury 2 1
40 F 66 90 Postsurgical pain N. tibialis peripheral nerve injury 5 3
41 F 71 65 Failed back surgery L 5-S 1 peripheral nerve injury 3 2
42 F 72 80 Failed back surgery L 4/5 peripheral nerve injury 2 2
43 F 75 80 Herniated nucleus pulposus L 4/5 peripheral nerve injury 4 2
44 M 23 70 Postsurgical pain TH 8/9 peripheral nerve injury 2 2
45 M 26 85 Accident with trauma C 8 peripheral nerve injury 5 0
46 M 32 40 Postsurgical pain TH 11 peripheral nerve injury 4 1
47 M 38 90 Accident with trauma N. brachialis peripheral nerve injury 1 6
48 M 47 80 Accident with trauma L 4/5 peripheral nerve injury 8 5
49 M 42 70 Failed back surgery L 5/6 peripheral nerve injury 7 2
50 M 43 90 Postsurgical pain TH 10/12 peripheral nerve injury 6 3
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indicating a dynamic allodynia.
Sensory Changes at the Patient’s Contralateral Side
Sensory abnormalities at the contralateral side ranged from no
abnormalities for CPT to 30.9% (n=25) for PPT. With the
exception of CPT, 95% Confidence Intervals confirmed that the
prevalence differed significantly from zero (p,0.05) for all QST
parameters with highest incidence for MPT (95CI: 11%-27%) and
PPT (95CI: 22%-42%) (Table 2B).
Overall there were less sensory abnormalities at the contralat-
eral side than at the affected side.
For nociceptive parameters there was predominantly sensory
gain observed, suggesting the presence of hyperalgesia, whereas for
non-nociceptive parameters predominantly a sensory loss was
identified suggesting hypoesthesia (Fig. 3).
Only sensory gain for HPT, PPT and WUR were observed
suggesting hyperalgesia. For MPT sensory loss was more
frequently observed than sensory gain indicating a greater
incidence for mechanical hyposensitivity than hypersensitivity. In
contrast, for MPS was sensory gain was more frequently observed
than sensory loss indicating a greater incidence for mechanical
hypersensitivity than hyposensitivity.
Thermal hypoesthesias were observed for most of the cases for
CDT and for TSL, only 7.4% of patients showed hyperesthesia for
TSL and 1.2% for CDT. WDT abnormalities were observed in
14.8% of the cases and this was due to both sensory loss and gain.
For MDT at the contralateral side sensory loss was observed three
times as often as sensory gain, indicating a greater incidence for
mechanical hypoesthesia. There was only hypoesthesia for VDT at
the contralateral side.
Table 1. Cont.
ID Gender Age NRS Cause of Pain Nerve Clinical diagnosis A.-side C.- side
51 M 49 40 Accident with trauma N. ulnaris peripheral nerve injury 2 1
52 M 50 70 Radiotherapy TH 2 peripheral nerve injury 1 4
53 M 50 75 Rib fracture TH 11 peripheral nerve injury 6 2
54 M 52 55 Postsurgical pain N. ulnaris CRPSII 2 2
55 M 53 45 Accident with trauma N. ulnaris peripheral nerve injury 2 2
56 M 55 50 Accident with trauma N. radialis peripheral nerve injury 2 1
57 M 56 55 Postsurgical pain N. axillaris peripheral nerve injury 1 1
58 M 58 40 Herniated nucleus pulposus C 5-C 7 peripheral nerve injury 0 0
59 M 58 80 Postsurgical pain N. radialis peripheral nerve injury 1 1
60 M 59 60 Accident with trauma N. radialis peripheral nerve injury 2 1
61 M 60 80 Postsurgical pain C 4 peripheral nerve injury 0 1
62 M 63 65 Accident with trauma N. digiti peripheral nerve injury 0 0
63 M 73 10 Herpes zoster TH 8 postherpetic neuralgia 0 0
64 M 24 50 Postsurgical pain N. Ilioinguinalis peripheral nerve injury 8 2
65 M 28 75 Postsurgical pain N. tibialis peripheral nerve injury 5 1
66 M 40 60 Amputation N. plantaris peripheral nerve injury 2 1
67 M 41 3 Failed back surgery S 1 peripheral nerve injury 4 1
68 M 43 60 Accident with trauma L 4 peripheral nerve injury 4 1
69 M 44 40 Accident with trauma N. femoralis peripheral nerve injury 1 0
70 M 44 35 Postsurgical pain N. Ilioinguinalis peripheral nerve injury 2 0
71 M 46 65 Failed back surgery L 4/5 peripheral nerve injury 0 0
72 M 47 75 Postsurgical pain N. tibialis peripheral nerve injury 4 1
73 M 51 70 Postsurgical pain N. femoralis peripheral nerve injury 3 0
74 M 53 70 Accident with trauma L 5 peripheral nerve injury 0 0
75 M 54 50 Postsurgical pain N. grenito-femoralis peripheral nerve injury 2 0
76 M 57 75 Tibia fracture N. tibialis peripheral nerve injury 5 4
77 M 62 70 Accident with trauma N. peroneus peripheral nerve injury 2 0
78 M 63 80 Postsurgical pain N. saphenus peripheral nerve injury 1 1
79 M 65 65 Herniated nucleus pulposus L 5 peripheral nerve injury 5 4
80 M 73 10 Peripheral nerve entrapment L 5-S 1 peripheral nerve injury 3 2
81 M 75 60 Postsurgical pain N. tibialis peripheral nerve injury 1 2
Demographic patient overview; Patient ID, gender and age are indicated. Patient’s rating of ongoing pain prior to Quantitative Sensory Testing (QST) using a Numeric
Rating scale (NRS) indicating ‘‘0’’ as ‘‘no pain’’ and ‘‘100’’ as the ‘‘most intense pain imaginable’’. Involved nerve indicates nerves (N.) or innervations area of nerves
affected in relation to the cause of pain. Number of QST abnormalities refers to parameter exceeding CI 95% of z-scores (,21.96 or .1.96) of values obtained from
healthy volunteers for the affected (A.) and contralateral (C.) side of patients.
doi:10.1371/journal.pone.0037524.t001
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contralateral side was detected. DMA was present in 19.8% of
patients, but mostly of very mild intensity. However, 3.7% of
patients showed a clinically relevant sensory gain for DMA
indicating a dynamic allodynia.
Example of Magnitude of Somatosensory Abnormalities
Here we describe one patient in greater detail for better
understanding of the magnitude of somatosensory abnormalities
based on raw values of the QST battery.
A 25 year old woman (ID1) suffered from a cut injury at her left
hand with a lesion of the digitalis nerve. Subsequently, she
developed severe pain at left palm including digits IV and V.
Bedside tests using von Frey filaments and a brush confirmed
impaired sensibility including allodynia of left hand. These sensory
signs were within neuroanatomical plausible distribution of the
digitalis nerve. The clinical diagnosis ‘‘peripheral nerve injury’’
was made. The QST assessment took place in the area of greatest
pain complaints and on the same contralateral site. Normative
data obtained from dorsal hand were from 63 age- and gender
matched volunteer’s 6 SD indicated in brackets. For the affected
side the patient rated the different pinprick forces with a NRS
score of 53.1 indicating an increased sensitivity for mechanical
pain (MPS) (0.6261.00). The NRS ratio for Wind up (WUR) test
was increased to 6.5 suggesting central sensitisation (NRS
2.5362.33). Her ratings for DMA pain of NRS 54.7 indicated
allodynia. Clinically, this QST profile indicates a predominant
gain of sensory function due to small and large fibre sensitisation.
Figure 2. Z-score profiles at the affected side and contralateral side in neuropathic pain patients. Sensory abnormalities (Z
score ,21.96 or .1.96) for each Quantitative Sensory Testing (QST) parameter at the affected side (left) and contralateral side (right) in 81
neuropathic pain patients. Grey area indicates parameters within the normal range (21.96,Z,1.96 corresponding with 95% of values obtained from
healthy volunteers). QST parameters: Cold Pain Threshold (CPT), Heat Pain Threshold (HPT), Warm Detection Threshold (WDT), Wind Up Ratio (WUR),
Cold Detection Threshold (CDT), Thermal Sensory Limen (TSL), Paradoxical Heat Sensation (PHS), Mechanical Pain Threshold (MPT), Mechanical Pain
Sensitivity (MPS), Mechanical Detection Threshold (MDT), Vibration Disappearance Threshold (VDT), Pressure Pain Threshold (PPT).
doi:10.1371/journal.pone.0037524.g002
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threshold for MDT of 0.5 mN (2.2262.27 mN) and a decreased
threshold for CDT of 24.9uC (30.760.77uC). DMA pain of NRS
3.5 indicates minor allodynia. Clinically, for the contralateral side
a predominant gain of sensory function was found indicating small
and large fibre sensitisation.
Sensory Changes at the Contralateral Side in Relation to
Sensory Changes at the Affected Side
To further investigate the extent of contralateral abnormalities
we determined the presence or absence of abnormalities in each
of the QST parameters at the contralateral side given that an
abnormality for the same parameter was present at the affected
side (Table 3). This occurred in 20% (for DMA) to 57% (for
PPT) of the cases (Fig. 4). Confidence Intervals (95%) confirmed
the prevalence to be significantly (p,0.05) different from zero for
all QST parameters, with the exemption of CPT (see Table 3).
The highest proportions were seen for the VDT (95CI: 20%-
57%) and PPT (95CI: 42%-71%). Although all proportions were
significant, some confidence intervals were very large due to
small numbers of observations. This was especially true for WUR
and for most of the thermal QST parameters.
To increase statistical power with the purpose to allow a
more accurate estimation of the prevalence of sensory abnor-
malities in the general chronic pain patient population, thermal
and mechanical QST parameters were combined into one
thermal and one mechanical domain. For the affected side this
grouping resulted in 21.4% (95CI: 18%–25%) thermal abnor-
malities and 29.0% (95CI: 25%–33%) mechanical abnormalities.
For the contralateral side 11.6% (95CI: 9%–14%) thermal
abnormalities and 13.7% (95CI: 11%–17%) mechanical abnor-
malities were found. To investigate the occurrence of bilateral
manifestations of sensory abnormalities we calculated the
prevalence of thermal and mechanical abnormalities at the
contralateral side given that there was an abnormality at the
affected side for the same QST domain in the same patient.
This resulted in 95% CI’s for bilateral abnormality ranging
from 12%–25% and 33%–50% for thermal and mechanical
QST domains, respectively.
Correlation between Background Pain and QST
Parameters
All patients reported ongoing spontaneous pain (NRS mean
64.1, SD 621.4) at their affected side before the QST assessment
took place (see Table 1). There were no significant correlations
found using Pearson correlations between background pain and
QST parameters. A significant correlation was found between
the frequencies of sensory abnormalities at the contralateral side
Table 2 Overview of sensory abnormalities in QST.
2A
QST parameter affected
side CPT HPT WDT WUR CDT TSL PHS MPT MPS MDT VDT PPT DMA
n of sensory abnormality 7 9 18 6 23 24 22 30 20 25 23 40 16
n o f s e n s o r y g a i n 793 5 112 2 72 0 314 0 1 6
n of sensory loss 0 0 15 1 22 23 0 23 0 22 22 0 0
% of sensory abnormality 8.6 11.1 22.2 8.8 28.4 29.6 27.2 37.0 24.7 30.9 28.4 49.4 19.8
Wilson estimates lower CI
95%
4.0 5.8 14.5 3.9 19.7 20.8 18.7 27.3 16.6 21.9 19.7 38.8 12.5
Wilson estimates upper CI
95%
17.1 20.1 32.5 18.4 39.1 40.4 37.8 47.9 35.2 41.7 39.1 60.0 29.9




CPT HPT WDT WUR CDT TSL PHS MPT MPS MDT VDT PPT DMA
n of sensory abnormality 0 9 12 7 13 13 8 14 10 8 8 25 3
n o f s e n s o r y g a i n 096 7 16828202 5 0
n o f s e n s o r y l o s s 006 0 1 2 701 2 26800
% of sensory abnormality 0.0 11.1 14.8 9.9 16.0 16.0 9.9 17.3 12.3 9.9 9.9 30.9 3.7
Wilson estimates lower CI
95%
20.9 5.8 8.6 4.6 9.5 9.5 4.9 10.5 6.7 4.9 4.9 21.9 0.9
Wilson estimates upper CI
95%
5.6 20.1 24.4 19.4 25.8 25.8 18.6 27.1 21.5 18.6 18.6 41.7 10.9
p,0 . 0 5 n . s . ** * *********
Patient numbers with sensory abnormalities at the affected (Table 2A, top) and contralateral side (Table 2B, bottom). Sensory abnormalities were defined as Z score
,2.96 or .1.96 corresponding with 95% of values obtained from healthy volunteers. Shown are direction (n of sensory gain/n of sensory loss) and overall
abnormalities in percent (% of sensory abnormality) for each Quantitative Sensory Testing (QST) parameters in 81 chronic pain patients. QST parameter: Cold Pain
Threshold (CPT), Heat Pain Threshold (HPT), Warm Detection Threshold (WDT), Wind Up Ratio (WUR), Cold Detection Threshold (CDT), Thermal Sensory Limen (TSL),
Paradoxical Heat Sensation (PHS), Mechanical Pain Threshold (MPT), Mechanical Pain Sensitivity (MPS), Mechanical Detection Threshold (MDT), Vibration Disappearance
Threshold (VDT), Pressure Pain Threshold (PPT) and Dynamic Mechanical Allodynia (DMA). Wilson estimates with upper and lower bound of the 95% CI for each QST
parameter (* p,0.05).
doi:10.1371/journal.pone.0037524.t002
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effect was supported by the correlation between the increase of
sensory loss at the contralateral side and background pain
(r=0.236; p=0.05).
Correlation between Numbers of Sensory Abnormalities
at the Affected and Contralateral Side
The number of sensory abnormalities for patients varied
between 0 and 8 for the affected and 0 and 6 for the contralateral
side for the thirteen QST parameters assessed (see Table 1). The
overall occurrence of contralateral abnormalities were significantly
correlated with abnormalities at the affected side (r=0.290;
p,0.01). Furthermore, a correlation was observed between the
presence of sensory loss at the affected and contralateral side
(r=0.300; p,0.01), whereas for the presence of sensory gain at the
affected and contralateral side a stronger correlation was found
(r=0.575; p,0.01).
Discussion
This QST study shows that patients with unilateral neuro-
pathic pain have a diversity of sensory abnormalities at the
Figure 3. Quantitative Sensory Testing (QST) abnormalities at the affected and contralateral side in neuropathic pain patients.
Quantitative Sensory Testing (QST) Z-score abnormalities in % at the affected (left) and contralateral side (right) in 81 neuropathic pain patients.
Sensory abnormalities were defined as Z score ,2 1.96 or .1.96 corresponding with 95% of values obtained from healthy volunteers. QST
parameter are ordered as sensory parameters: Cold Detection Threshold (CDT), Warm Detection Threshold (WDT), Thermal Sensory Limen (TSL),
Mechanical Detection Threshold (MDT), Vibration Disappearance Threshold (VDT), Paradoxical Heat Sensation (PHS), Dynamic Mechanical Allodynia
(DMA) and nociceptive parameters: Cold Pain Threshold (CPT), Heat Pain Threshold (HPT), Pressure Pain Threshold (PPT), Mechanical Pain Threshold
(MPT), Mechanical Pain Sensitivity (MPS) and Wind Up Ratio (WUR). Z-scores with positive sensory signs (gain of sensory function) plotted rightwards
and negative sensory signs (loss of sensory function) plotted leftwards. Absence of DMA is normal and therefore no negative sign possible.
doi:10.1371/journal.pone.0037524.g003
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painful side. Using the standardized QST protocol with 13
different parameters to obtain a complete sensory profile, it was
demonstrated that bilateral sensory abnormalities are apparent in
a considerable number of the patients that experience chronic
unilateral pain.
There was a significant correlation between the number of
abnormalities at the painful side and the contralateral side. Even
more so, if a particular abnormality was detected at the painful
side, this abnormality was then the most likely abnormality to
occur contralaterally. This was particularly striking for the
mechanical stimuli group where the estimated prevalence of
sensory abnormalities at the non-painful side was 33%–50% (95%
CI) once a mechanical abnormality was detected at the painful
side. These results have implications for the evaluation of patients
in clinical practice, since often the non-affected side is used as the
reference side. Our results show that using the contralateral side as
the reference to identify sensory abnormalities at the affected side
might lead to misinterpretation of the clinical manifestation.
Table 3 Overview of sensory abnormalities at the contralateral side given an abnormality at the affected side.
QST parameter CPT HPT WDT WUR CDT TSL PHS MPT MPS MDT VDT PPT DMA
n of sensory gain similar
to affected side
0 3 2 2 01617002 3 2
n of sensory loss similar
to affected side
0 0 3 0 530704800
% of sensory abnormality
similar to affected side
0.0 38.5 31.8 44.4 26.9 22.2 30.8 29.4 37.5 23.1 38.5 56.8 20.0
Wilson estimates lower CI 95% 24.6 12.0 12.4 12.0 9.9 6.8 13.0 14.1 18.1 6.9 19.8 42.2 2.5
Wilson estimates upper CI 95% 41.0 64.9 51.3 76.9 44.0 37.6 48.5 44.7 56.9 39.3 57.2 71.5 37.5
p,0 . 0 5 n . s . * * * *********
Patient numbers with sensory abnormalities and in their direction (n of sensory gain/n of sensory loss). Sensory abnormalities were defined as Z score ,2 1.96 or .1.96
corresponding with 95% of values obtained from healthy volunteers. Percent (% of sensory abnormality) indicates overall occurrence of sensory abnormalities for each
Quantitative Sensory Testing (QST) parameter at the contralateral side once there was already an abnormality for the same parameter detected at the affected side in 81
chronic pain patients. QST parameters: Cold Pain Threshold (CPT), Heat Pain Threshold (HPT), Warm Detection Threshold (WDT), Wind Up Ratio (WUR), Cold Detection
Threshold (CDT), Thermal Sensory Limen (TSL), Paradoxical Heat Sensation (PHS), Mechanical Pain Threshold (MPT), Mechanical Pain Sensitivity (MPS), Mechanical
Detection Threshold (MDT), Vibration Disappearance Threshold (VDT), Pressure Pain Threshold (PPT) and Dynamic Mechanical Allodynia (DMA). Wilson estimates with
upper and lower bound of the 95% CI for each QST parameter (* p,0.05).
doi:10.1371/journal.pone.0037524.t003
Figure 4. Incidence of QST abnormalities at the contralateral side in neuropathic pain patients. Incidence of QST abnormalities at the
contralateral side in 81 neuropathic pain patients. Sensory abnormality in percent (%) of either gain or loss of function for each Quantitative Sensory
Testing (QST) parameter at the contralateral side once there was already an abnormality detected for the same parameter at the affected side.
Sensory abnormalities were defined as Z score ,2 1.96 or .1.96 corresponding with 95% of values obtained from healthy volunteers. QST
parameter in this radar diagram are ordered as mechanical stimuli consisting of Mechanical Pain Threshold (MPT), Dynamic Mechanical Allodynia
(DMA), Pressure Pain Threshold (PPT), Vibration Disappearance Threshold (VDT), Mechanical Detection Threshold (MDT), Mechanical Pain Sensitivity
(MPS) and Wind Up Ratio (WUR) (left side) and thermal stimuli consisting of Cold Pain Threshold (CPT), Heat Pain Threshold (HPT), Warm Detection
Threshold (WDT), Cold Detection Threshold (CDT), Thermal Sensory Limen (TSL), Paradoxical Heat Sensation (PHS) (right side).
doi:10.1371/journal.pone.0037524.g004
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Z-score transformation of QST data revealed one or more
somatosensory abnormalities in 36% of all members of the healthy
control group. This number is in line with previous findings
reporting 41% abnormalities using the QST protocol [16].
In our healthy volunteers, abnormalities were observed across
all QST parameters with the exception of DMA. The detected
sensory abnormalities reflected gain of function for the most part,
some loss of function and in a minority fraction both gain and loss
of function (Fig. 1).
Although previously reported otherwise [16], in the present
study, PHS .1 occurred in 1.4% at the test side ‘‘dorsal hand’’
and in 9.3% at the test side ‘‘dorsal foot’’. The presence of
abnormal PHS in our study could be associated with a greater
likelihood of sensory dysfunction with an increase in age (r=0.193;
p,0.01).
Sensory Signs at the Affected, Painful Side of
Neuropathic Pain Patients
As expected, the large majority (91%) of neuropathic pain
patients showed sensory abnormalities at their affected side. Maier
and colleagues (2010) [16] reported a similar percentage (92%) of
patients with at least one QST abnormality. Given the fact that for
9% of the patients, no abnormality could be detected, QST and
the cut-off of 95% CI of the mean reference values might possibly
be more stringent than clinical examination.
In accordance with previous studies, sensory loss was predom-
inantly found in non-nociceptive parameters [16,18] which could
be associated with central or peripheral neuronal damage which
might lead to ongoing pain via increased ectopic activity
[19,20,21]. Sensory gain was predominantly found in nociceptive
parameters which could be associated with peripheral sensitization
and/or altered central processing [10,22,23,24,25].
Maier and co-workers (2010) reported abnormal QST values
for the affected side across the different clinical neuropathic pain
entities ranging between 8%–36% (compared to 7%–48% in this
study) [16]. There was good agreement between our estimates of
the expected range of sensory abnormalities in the general
neuropathic pain patient population and those reported by Maier
[16]. Only estimate ranges for the occurrence of sensory
abnormalities for CDT, WUR, TSL, MDT, MPT and VDT in
the present study differed slightly but were still in close proximity
to the values reported previously [16].
Contralateral Sensory Signs in Neuropathic Pain Patients
Contralateral sensory changes in patients with chronic pain
have been acknowledged in a number of clinical studies
[3,4,5,26,27,28,29]. For instance it was reported that 5% of the
patients with complex regional pain syndrome (CRPS) present
bilateral symptoms [30]. Despite reports of the existence of
bilateral changes in chronic pain patients, no elaborate quantita-
tive data have been published. In the present QST study, sensory
abnormalities at the contralateral side were observed for all QST
parameters.
Comparing the overall sensory findings from the contralateral
side with those obtained from the healthy controls, a significant
difference was shown indicating abnormal sensory function at the
contralateral side in patients with unilateral neuropathic pain. In
addition, a significant correlation was found for abnormal sensory
function at the contralateral sides compared to the affected side.
The pattern of sensory abnormalities for nociceptive and non-
nociceptive parameters at the contralateral side was in line with
that at the affected side but less severe. All patients had unilateral
pain causing events and most showed bilateral sensory abnormal-
ities. This finding points to a central component in processing the
pain and controlling sensory function bilaterally.
Preclinical studies have also found evidence for bilateral sensory
changes upon unilateral induction of pain and these studies
correlated the severity of pain with occurrence of bilateral
changes. Hubbard and colleagues (2008) demonstrated in a rat
model using painful cervical nerve root compression that the
occurrence of contralateral allodynia depended on the load of
compression [31]. In another study, zymosan induced sciatic
neuritis in rats, causing a dose-dependent bilateral allodynia [32].
In healthy volunteers and patients with rheumatoid arthritis, an
intradermal administration of capsaicin induced mechanical
hyperalgesia and allodynia at the side contralateral to the injection
area [29]. Studies using capsaicin revealed that short-lasting but
high intensity pain induces contralateral sensory changes [7;21].
These results suggest that pain intensity may play a prominent role
in contralateral sensory changes. Potential underlying conditions
which may lead to contralateral sensory changes in unilateral pain
condition are currently being investigated. Koltzenburg et al. [33]
suggested the involvement of nerve growth factors (NGF) to
explain the contralateral peripheral responses in rats with
unilateral neural injuries. Other studies suggested the involvement
of altered glial activation and spinal pro-inflammatory cytokines
(tumour necrosis factor (TNF), interleukin-1 (IL-1), interleukin-6
(IL-6)) [34,35,36,37].
In line with these findings, in the present study we have also
found a significant correlation between background pain and QST
abnormalities at the contralateral side in patients who experienced
a unilateral pain-causing event. This supports previous suggestions
that high pain intensities can induce sensory abnormalities at the
contralateral side in patients with unilateral pain. Additional
studies are needed to evaluate, for instance, if the severity of pain
determines the onset of contralateral changes and if ongoing pain
is the driving force for the maintenance of contralateral
abnormalities in chronic pain patients.
Correlation between Sensory Changes at Affected and
Contralateral Side
An interesting finding is that the presence of sensory gain or loss
at the affected side was related to sensory gain or loss for the same
QST parameter at the contralateral side, ranging from 20% to
57% dependent on the QST parameter. In particular for the
group of mechanical stimuli, the estimated presence of sensory
abnormalities at the non-affected side was substantial (ranging
from 33%–50%). Although sensory abnormalities at the contra-
lateral side were less pronounced compared to those at the affected
side, there was a significant correlation between the numbers of
sensory abnormalities at both sides in patients.
Contrary to recommendations to use the contralateral side as a
reference to identify sensory abnormalities in patients [1,38] our
data indicate that this is not advisable since the sensory function at
the contralateral side stands a reasonable chance of being altered.
The interpretation of sensory signs and subsequent clinical
manifestations using the contralateral side or reference values
from healthy volunteers may vary (see Table 4 for examples).
Since most (n=77) patients in the present study continued their
pain medication it cannot be excluded that the medication itself
might have influenced the onset or maintenance of somatosensory
changes seen bilaterally.
These results firmly establish evidence for a cautious use of the
contralateral side as a reference site in clinical practice. A way to
overcome this problem is the use of reference values for either
normative response or for pathological response to QST
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ities in patients.
In conclusion, our data provide detailed evidence for bilateral
sensory abnormalities in unilateral neuropathic pain patients using
a standardized, elaborate QST protocol. Our results show that in
these patients, the contralateral side should not be regarded as
normal or healthy per se. This has implications for appropriate
diagnostic evaluation in clinical practice.
Supporting Information
Table S1 Quantitative Sensory Testing normative data
of healthy volunteers. Quantitative Sensory Testing (QST)
normative values assessed on dorsal hand (A) and dorsal foot (L)
for female (F) and male (M) according to three age groups (18–45
years (y), 46–60 years and 61–75 years of age) in healthy
volunteers. QST parameters: Cold Pain Threshold (CPT), Heat
Pain Threshold (HPT), Warm Detection Threshold (WDT), Wind
Up Ratio (WUR) (intensity of perception of single vs. series of
1 Hz stimuli as NRS), Cold Detection Threshold (CDT), Thermal
Sensory Limen (TSL), Paradoxical Heat Sensation (PHS),
Mechanical Pain Threshold (MPT), Mechanical Pain Sensitivity
(MPS), Mechanical Detection Threshold (MDT), Vibration
Disappearance Threshold (VDT), Pressure Pain Threshold
(PPT). The absence of DMA is normal and therefore described.
Numeric Rating scale (NRS) indicate ‘‘0’’ as ‘‘no pain’’ and ‘‘100’’
as the ‘‘most intense pain imaginable’’. Unit of each QST
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